Inventor
WOOD JILL E
US14 patents
⚠️ This page may combine multiple inventors who share the name “WOOD JILL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
8 patentsUS7329670B1Feb 12, 2008
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
BAYER PHARMACEUTICALS CORP76 citations97
US7235576B1Jun 26, 2007
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP94 citations97
US7351834B1Apr 1, 2008
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP64 citations96
US7517880B2Apr 14, 2009
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
BAYER PHARMACEUTICALS CORP25 citations90
US6900205B2May 31, 2005
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
BAYER PHARMACEUTICALS CORP19 citations90
US6784167B2Aug 31, 2004
17-beta-hydroxysteroid dehydrogenase-II inhibitors
BAYER PHARMACEUTICALS CORP35 citations89
US7371763B2May 13, 2008
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER PHARMACEUTICALS CORP17 citations83
US7109196B2Sep 19, 2006
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
BAYER PHARMACEUTICALS CORP7 citations71
BAYER HEALTHCARE LLC
3 patentsUS7897623B2Mar 1, 2011
ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
BAYER HEALTHCARE LLC35 citations92
US7625915B2Dec 1, 2009
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
BAYER HEALTHCARE LLC33 citations92
US7928239B2Apr 19, 2011
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER HEALTHCARE LLC15 citations83